Jiangsu Recbio Technology Co., Ltd. (2179.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap1.91B
Enterprise Value2.2B
P/E Ratio-4.19
PEG Ratio-0.08
Price/Sales Ratio157.06
Price/Book Ratio3.99
Enterprise/Revenue209.31
Enterprise/EBITDA-5.45

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-51.34
Operating Margin-50.01
AD

Management Effectiveness

Return On Assets-0.3
Return On Equity-0.79

Income Statement

Revenue12.4M
Revenue/Share0.02
Gross Profit-91.46M
EBITDA-483.72M
Net Income-594.59M
Diluted EPS-1.12

Balance Sheet

Total Cash187.51M
Total Cash/Share0.3
Total Debt672.99M
Total Debt/Equity1.35
Current Ratio0.53
Book Value Per Share0.81

Price History

52-Week Change-45.71
52-Week High7.2
52-Week Low1
Moving Average 50 Days4.71
Moving Average 200 Days4.8

Statistics

Average Volume1,023
Shares Outstanding451.97M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD